Garinet S, Semaan K, Li J, et al. Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinoma. The Journal of clinical investigation. 2026;136(3). doi:10.1172/JCI195725
Cancer Program
Abbott KL, Subudhi S, Ferreira R, et al. Nutrient requirements of organ-specific metastasis in breast cancer. Nature. 2026. doi:10.1038/s41586-025-09898-9
Jun H, Tanaka Y, Johri S, et al. A context-augmented large language model for accurate precision oncology medicine recommendations. Cancer cell. 2026. doi:10.1016/j.ccell.2025.12.017
Ding T, Wagner SJ, Song AH, et al. A multimodal whole-slide foundation model for pathology. Nature medicine. 2025. doi:10.1038/s41591-025-03982-3
Siegel F, Siegel S, Kotýnková K, et al. Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer. Cancer discovery. 2025. doi:10.1158/2159-8290.CD-25-0605
Parsons HA, Messer C, Santos K, et al. Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA. Cell genomics. 2025:100987. doi:10.1016/j.xgen.2025.100987
Lightbody ED, Sklavenitis-Pistofidis R, Wu T, et al. SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursors. Nature cancer. 2025. doi:10.1038/s43018-025-01006-0
Shanmugam V, Tokcan N, Chafamo D, et al. Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors. Nature communications. 2025. doi:10.1038/s41467-025-67539-1
Zheng C, Khan A, Ritter D, et al. Pancreatic cancer risk prediction using deep sequential modeling of longitudinal diagnostic and medication records. Cell reports. Medicine. 2025;6(9):102359. doi:10.1016/j.xcrm.2025.102359
Apfelbaum AA, Morin E, Sturm D, et al. A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas. Nature communications. 2025;16(1):7018. doi:10.1038/s41467-025-61820-z